Event Type
Disclosure
Voluntary
Variant
8-K
is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherw
Other Events. ABI-1179 The Company announced interim results from the 1179 Study. For the powered antiviral endpoint, HSV type 2 ("HSV-2") shedding rate, highly
Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press Release dated December 8, 2025. 104 Cover Page Interactive Data File (em